BM, Regmi, 刘建平, 屠锡德. 乙吗噻嗪胃内滞留漂浮型缓释片的研究J. 药学学报, 1996, 31(1): 54-58.
引用本文: BM, Regmi, 刘建平, 屠锡德. 乙吗噻嗪胃内滞留漂浮型缓释片的研究J. 药学学报, 1996, 31(1): 54-58.
BM Regmi, JP Liu , XD Tu, . STUDIES ON ETHMOZINE SUSTAINED-RELEASE TABLET REMAINING-FLOATING IN STOMACHJ. Acta Pharmaceutica Sinica, 1996, 31(1): 54-58.
Citation: BM Regmi, JP Liu , XD Tu, . STUDIES ON ETHMOZINE SUSTAINED-RELEASE TABLET REMAINING-FLOATING IN STOMACHJ. Acta Pharmaceutica Sinica, 1996, 31(1): 54-58.

乙吗噻嗪胃内滞留漂浮型缓释片的研究

STUDIES ON ETHMOZINE SUSTAINED-RELEASE TABLET REMAINING-FLOATING IN STOMACH

  • 摘要: 研制了乙吗噻嗪胃内滞留漂浮型缓释片剂(E-HBS)。实验结果表明:本品的体外溶出符合一级动力学过程(Kr=0.2436h-1);人体胃内γ-闪烁照像显示E-HBS在胃内滞留时间长达6h以上,明显长于市售普通片(ECT1~1.5h);血药浓度经时曲线平缓持久,达到良好的缓释效果;体内外实验数据有显著的相关性(P<0.01)。

     

    Abstract: An oral sustained-release system of cthmozm0(E-HBS)was developed.The in vitro release characteristics of E-HBS were shown primarily to be of the first order of kinetics(Kr=0.2436h-1).The γ-scintiphotographic study showed that E-HBS remained in the human stomach formore than 6 hours after ingestion,much longer than the conventional tablet(1~1.5h).The plasmaconcentration-time curve of E-HBS exhibited typical sustained-release characteristics.The percentageof drug released in vitro vs the percentage of drug release in vivo of E-HBS indicated excellent linearity.

     

/

返回文章
返回